Sensus Healthcare To Showcase Its Full Line Of Cutting-Edge Superficial Radiotherapy Devices For The Treatment Of Non-Melanoma Skin Cancer At ASTRO 2023 In San Diego
Portfolio Pulse from Benzinga Newsdesk
Sensus Healthcare, Inc. (NASDAQ:SRTS) will present its full line of superficial radiotherapy (SRT) devices for the treatment of non-melanoma skin cancer and keloids at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego from October 1-4. The company's devices utilize the Multi-Dimensional Superficial Radiotherapy platform, which provides an alternative low-energy X-ray treatment for various types of non-melanoma skin cancer and keloids.
September 26, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sensus Healthcare's participation in ASTRO 2023 and showcasing of its SRT devices could potentially increase its visibility and market reach, possibly leading to increased sales and positive impact on its stock.
Sensus Healthcare's participation in a major industry event like ASTRO 2023 increases its visibility among industry professionals and potential customers. Showcasing its SRT devices, which offer a non-invasive and effective treatment for non-melanoma skin cancer and keloids, could attract more customers and increase sales. This could potentially lead to a positive impact on the company's stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100